Publication of Biohit Oyj Annual Report 2012

Biohit Oyj March 18, 2013 at 11:30 local time (EET)

Biohit Oyj’s Annual Report 2012 is published today as PDF document. The annual report contains a review of information published in 2012.

Report is available in English and Finnish at Biohit company website www.biohithealthcare.com/investors. Printed publication of Annual Report 2012 will be distributed to shareholders in Annual General Meeting.

Additional information:

CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
semi.korpela@biohit.fi
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology established in 1988. Biohit’s mission is “Innovating for Health”. The purpose of the company is to take social responsibility and produce innovation, new technologies and analysis systems for use in medicine, research institutions and industry, helping to promote research and diagnostics and to improve the quality of life of people by means of preventing disease, human suffering and financial loss. We are committed to responsibility and it is our duty to innovate and develop the marketing and availability of our products and services. Biohit is headquartered in Helsinki and its subsidiaries are located China and UK. Since 1999, Biohit’s Series B shares (BIOBV) have been listed in the NASDAQ OMX Helsinki Oy Small cap/Healthcare sector.